CEO Today USA Awards

25 www.ceotodaymagazine.com CEO Today USAAwards 2018 CALIFORNIA MICK FARRELL CEO of ResMed ABOUT MICK FARRELL Mick Farrell was appointed ResMed’s CEO in March 2013. He joined the company in 2000, serving as president of the Americas region from 2011 to 2013, senior vice president of the global sleep apnea business unit from 2007 to 2011, and various senior roles in marketing and business development. Before joining ResMed, Mick worked in management consulting, biotechnology, chemicals and metals manufacturing at Arthur D. Little, Genzyme Corporation (now part of Sanofi), The Dow Chemical Company, and BHP Billiton. Mick serves on the board of directors of ResMed, the Advanced Medical Technology Association (AdvaMed) and Zimmer Biomet (NYSE: ZBH), a multibillion dollar public company that provides implantable musculoskeletal medical devices for patients globally. He is also a member of two committees at Zimmer Biomet: Nominating and Governance as well as Compensation and Management Development. He also volunteers as a trustee for non-profit organizations: UC San Diego Foundation, Rady Children’s Hospital, the La Jolla Playhouse, and the Museum of Man in San Diego. Mick holds a bachelor of engineering with first-class honors from the University of New South Wales, a Master of Science in chemical engineering from the Massachusetts Institute of Technology, and a Master of Business Administration from the MIT Sloan School of Management. www.resmed.com FIRM PROFILE ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 6 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries. At ResMed, we believe that every breath is a gift. And from the day we began pioneering sleep apnea treatment options in 1989, our aim has been to deliver life-changing products and solutions to patients with sleep apnea and other respiratory conditions worldwide, and to spread awareness about these conditions and treatments. Our logo, ResMed’s signature blue-to-red pulse curve, depicts a single healthy breath – our goal for every sleep apnea and respiratory care patient, every time. It symbolizes how our blood becomes oxygenated with every breath and beat of the heart, and represents the very reason ResMed is here today: to make every breath another chance for positive change. Our mission is to change 20 million lives by 2020. We’re proud to make equipment and connected health solutions that give those with sleep apnea, COPD and other respiratory diseases the gift of breath. Aims and objectives Our aim is to deliver life-changing products and connected health solutions to patients worldwide with sleep apnea or other respiratory conditions, and to spread awareness about these conditions and treatments. Our objective is two-fold: Provide life-changing diagnoses and treatments to patients with sleep apnea, COPD and other respiratory diseases; and Enable remote and self-monitoring via our therapy devices to improve patients’ experiences, outcomes and health, as well as clinicians’ patient management efficiency. We sell a comprehensive range of products in more than 120 countries worldwide through direct offices and a network of distributors. Plus more than 4 million ResMed devices are cloud-connected, sharing actionable data with clinicians and patients themselves to improve their therapy experience, adherence and overall health. Dedicating 7 percent of annual revenue to research and development, we are committed to advancing innovative technology in sleep and respiratory medicine, to commercializing innovative products that incorporate these technologies around the world, and exercising the highest standards of ethics and quality at all times.